Ontvang nu dagelijks onze kooptips!

word abonnee
IEX 25 jaar desktop iconMarkt Monitor

Aandeel ProQR Therapeutics NV OTC:PRQR.Q, NL0010872495

Vertraagde koers (usd) Verschil Volume
3,625   -0,105   (-2,82%) Dagrange 3,460 - 3,800 473.112   Gem. (3M) 1,3M

ProQR Therapeutics 2021

291 Posts
Pagina: «« 1 ... 7 8 9 10 11 ... 15 »» | Laatste | Omlaag ↓
  1. PlayBall10 6 mei 2021 14:36
    www.proqr.com/press-releases/proqr-an...

    ProQR Announces First Quarter 2021 Operating and Financial Results
    - Phase 2/3 pivotal Illuminate trial of sepofarsen for LCA10 enrollment complete with top-line data anticipated in H1 2022
    - Positive data reported from the Phase 1/2 clinical trial of QR-421a for the treatment of Usher syndrome and non-syndromic retinitis pigmentosa, with plans to advance the program into two pivotal Phase 2/3 trials before year end
    - Exclusive worldwide license and discovery collaboration for non-ophthalmic target with Yarrow Biotechnology, an RTW Investments, LP incubated company
    - Strengthened balance sheet with $103.5 million gross proceeds from public offering
  2. Missolapola 10 juni 2021 20:13
    ProQR to Present at Upcoming JMP Securities Life Sciences Conference

    LEIDEN, Netherlands & CAMBRIDGE, Mass., June 10, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today announced that Company management will present during a fireside chat at the upcoming JMP Securities Life Sciences Conference. The presentation will be webcast live on June 17, 2021, from 3:00 – 3:25pm EDT.
    The live and archived webcast of the presentation will be accessible from the “Investors & Media” section of ProQR’s website (www.proqr.com) under “Events”. The archived webcast will be available for approximately 30 days following the presentation date.
291 Posts
Pagina: «« 1 ... 7 8 9 10 11 ... 15 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.